IRIS
ORANGER, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.602
EU - Europa 1.077
AS - Asia 359
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.043
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.601
SE - Svezia 337
CN - Cina 313
IT - Italia 291
UA - Ucraina 145
DE - Germania 119
FI - Finlandia 83
GB - Regno Unito 51
IN - India 26
IE - Irlanda 21
FR - Francia 19
IR - Iran 7
BE - Belgio 6
SG - Singapore 6
AU - Australia 3
KR - Corea 3
VN - Vietnam 3
AT - Austria 1
BO - Bolivia 1
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
Totale 5.043
Salva come PNG Salva come JPEG
Città #
Fairfield 401
Chandler 393
Jacksonville 348
Woodbridge 332
Nyköping 249
Houston 223
Ashburn 186
Cambridge 179
Bari 174
Ann Arbor 170
Seattle 155
Wilmington 133
Roxbury 92
Lawrence 90
Nanjing 85
New York 64
Des Moines 62
Beijing 59
Princeton 41
Boardman 40
Inglewood 38
Dearborn 37
Brooklyn 32
San Diego 32
Shenyang 30
Nanchang 25
Pune 23
Dublin 21
Los Angeles 19
London 18
Hebei 17
Changsha 16
Jiaxing 16
Noicattaro 15
Tianjin 14
Trani 14
Redwood City 12
Paris 10
Boydton 9
Hefei 9
Orta Nova 9
Ardabil 7
Falls Church 7
Kunming 7
Melito Di Napoli 7
Norwalk 7
Brussels 6
Leawood 6
San Mateo 6
Singapore 6
Grumo Appula 5
Indiana 5
Jinan 5
Augusta 3
Bologna 3
Dong Ket 3
Fuzhou 3
Kilburn 3
Nanning 3
Ningbo 3
Nürnberg 3
Rome 3
Taizhou 3
Washington 3
Acton 2
Auburn Hills 2
Chiswick 2
Guangzhou 2
Mottola 2
Mumbai 2
Novi Ligure 2
Pieve di Cento 2
Roccapiemonte 2
San Francisco 2
Strasbourg 2
Xian 2
Zhengzhou 2
Agoura Hills 1
Ankara 1
Athis-mons 1
Bitritto 1
Brisbane 1
Brno 1
Cerignola 1
Chengdu 1
Costa Mesa 1
Cutrofiano 1
Foggia 1
Fremont 1
Genova 1
Grafing 1
Groningen 1
Harbin 1
Helsinki 1
Hounslow 1
Huzhou 1
Jastrebarsko 1
Klagenfurt 1
Lecce 1
Manchester 1
Totale 4.048
Salva come PNG Salva come JPEG
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 140
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 126
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 124
Sclerostin stimulates angiogenesis in human endothelial cells 110
TRAIL effect on osteoclast formation in physiological and pathological conditions 102
Osteogenic differentiation of dental follicle stem cells. 98
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 97
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 94
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 90
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 87
TRAIL is involved in human osteoclast apoptosis 84
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 82
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 80
null 74
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 73
null 71
Elevati livelli sierici di Dkk1, antagonista del segnale di WNT in bambini obesi. 70
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process 70
The Role of LIGHT in Multiple Myeloma-Bone Disease 69
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 68
THE ROLE OF LIGHT ON BONE REMODELING 66
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 66
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 65
Myeloma cells suppress osteoblasts through sclerostin secretion 65
Cellular mechanisms of multiple myeloma bone disease 64
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 64
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 64
null 63
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 59
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 59
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 58
Dental pulp stem cells: osteogenic differentiation and genes expression 58
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 57
null 57
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 56
Another link between bone and immune system: LIGHT 55
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 54
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 53
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 53
Myeloma cells induce osteoblast suppression through sclerostin secretion 52
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 51
Failure of an in vitro model of osteoclastogenesis in human plasma cell leukaemia (PCL) 51
Spontaneous osteoclastogenesis TNF-a and RANKL mediated in patients with Turner syndrome. 50
Mechanism of Bone Disease in Prader-Willi Syndrome 50
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 50
Soluble decoy receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 49
Sclerostin, produced by myeloma plasma cell, suppresses osteoblast activity 49
Osteoclast apoptosis: Role of TRAIL and its receptors 49
null 49
The role of the Wnt-signaling antagonist Sclerostin in the development of osteolytic lesions in multiple myeloma 48
No spontaneous osteoclast formation in an in vitro model derived from primary plasma cell leukemia 48
LIGHT: another link between bone and immune system 47
The effect of Irisin on bone cells in vivo and in vitro 46
LIGHT: a new potential molecule involved in bone loss 44
Osteogenic properties of human dental pulp stem cells 44
Impairment of osteoblast diffeentiation and activity through sclerostin in multiple myeloma bone disease ??? 44
Osteoclast formation in Multiple Myeloma bone disease patients: role of DcR3 43
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 43
Inflammatory Cells in Diffuse Large B Cell Lymphoma 43
DcR3 involvement in multiple myeloma bone disease 42
DCR3 involvement in multiple myeloma bone disease 42
Survival and formation of osteoclasts from multiple myeloma bone disease patients: role of decoy receptor 3 (DCR3) 41
null 41
Ridotta attività degli osteoblasti nel mieloma multiplo: ruolo della sclerostina 40
The role of the Wnt-signaling antagonist sclerostin in the development of osteolytic lesions in multiple myeloma 40
Evaluation of serum levels of cathepsin k in multiple myeloma patients 39
Formazione e sopravvivenza di osteoclasti in pazienti affetti da mieloma multiplo: ruolo di DcR3 39
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 39
High serum levels of the WNT-signaling antagonist Dkk1 in children with 21-hydroxylase deficiency (21-OHD) 38
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 37
Circulating levels of cathepsin-k in multiple myeloma patients 37
High serum levels of the WNT-signaling antagonist Dkk1 in obese children 36
Osteoclastogensi spontanea TNF-alpha e RANKL mediata in pazienti con Sindrome di Turner 35
Inhibition of osteoclast apoptosis in multiple myeloma bone diseases: role of DCR3 35
Shedding LIGHT on bone cell differentiation and Multiple Myeloma-bone disease 35
TRAIL effect on osteoclast formation in multiple myeloma-bone disease 34
Le cellule T supportano la formazione di osteoclasti in vitro in campioni di sangue periferico ottenuti da pazienti affetti da artrite psoriasica 34
DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNFα up-regulation 33
Osteoblast apoptosis in periodontal disease: role of TRAIL 33
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 31
Decoy Receptor 3 DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNF-ALPHA up-regulation 31
Irisin and Secondary Osteoporosis in Humans 30
Ruolo di LIGHT (tnfsf14) nella malattia ossea associata al mieloma multiplo 29
ROLE OF DCR3 ON OSTEOCLAST FORMATION IN MULTIPLE MYELOMA BONE DISEASE PATIENTS 29
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 28
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 26
Bone Cells 26
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 26
Detection of the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 25
Suppressed osteoblast differentiation and activity in multiple myeloma bone disease: role of sclerostin 25
The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of solubile decoy receptor 3 23
Ridotta attività degli osteoclasti nel mieloma multiplo: ruolo di sclerostina 23
Osteoclast formation and survival in multiple myeloma bone disease patients: role of DcR3 23
The role of light (TNFSF14) on bone remodeling 23
Role of DcR3 on osteoclast formation in multiple myeloma bone disease patients. 20
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 19
Solubile decoy receptor 3 (DCR3) modulates the survival of osteoclasts derived from patients with multiple myeloma lytic bone disease 17
DcR3 involvement in multiple myeloma bone disease 16
Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome 14
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 13
Totale 5.142
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019213 0 0 0 0 0 0 0 0 0 0 95 118
2019/20201.075 220 64 33 56 91 73 132 77 119 60 128 22
2020/2021808 91 27 77 22 88 48 85 52 109 111 65 33
2021/2022786 23 107 5 32 26 49 28 35 125 40 130 186
2022/20231.143 163 125 65 85 140 133 21 132 226 5 20 28
2023/2024384 44 82 14 27 37 115 8 4 1 30 22 0
Totale 5.197